文献速递其他结缔组织病

增加舍格伦病患者的小唾液腺数量可提高组织学灶性评分的诊断与测量精确度

Increasing the number of minor salivary glands from patients with Sjögren's disease improves the diagnostic and measurement precision of the histological focus score.
PubMed 文献 · Ann Rheum Dis · 2025-02-17

该研究通过蒙特卡洛模拟评估小唾液腺(MSG)数量对舍格伦病诊断(灶性评分FS≥1)、可重复性及临床试验样本量的影响。结果显示MSG数量增加可提高可重复性并降低所需样本量,建议诊断目标至少取5个腺体,连续FS值可取6个。

要点

  • 诊断阈值FS≥1时,理想情况下应至少取5个小唾液腺。
  • 连续FS值评估时,取6个或更多腺体可进一步提高可重复性并减少样本量。
  • MSG数量从2增至7时,两次FS测量的中位绝对差从1.05降至0.52。

核心结论

  • 对于FS≥1的诊断阈值,理想情况下应至少针对5个腺体。
  • 对于连续FS值,更多MSG(如6个)将进一步增加可重复性并降低临床试验样本量需求。

研究设计与样本

  • 采用蒙特卡洛模拟研究MSG数量(范围2-7个)对诊断、可重复性及样本量的影响。
  • 可重复性定义为假设两次活检间无系统差异时,2次患者内活检所得2次FS测量的一致性程度。

主要发现

  • MSG数量每增加1个,可重复性均提高,两次患者内FS测量的中位绝对差从2个腺体的1.05(SD=0.25)降至7个腺体的0.52(SD=0.12)。
  • MSG数量影响模拟患者获得FS≥1的概率,从2个腺体的中位0.67增至≥5个腺体的0.77。
  • MSG数量影响临床试验样本量,例如检测40%的FS降低达80%统计功效时,2个腺体每组需62例,7个腺体每组需25例。

关键数值与推荐

  • 诊断阈值FS≥1时,理想情况下应至少针对5个腺体。
  • 连续FS值评估时,更多MSG(如6个)可进一步增加可重复性并降低临床试验样本量需求。

临床怎么用

  • 对于基于FS≥1的诊断,理想情况下应至少取5个小唾液腺。
  • 对于连续FS值测量,可考虑取6个或更多小唾液腺以提高可重复性并降低临床试验样本量需求。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Minor salivary gland (MSG) biopsy has an important role in Sjögren's disease diagnosis and research. MSGs show within-patient variation in number of lymphocytic foci per unit area, but the optimal number of MSGs required to balance reproducibility and clinical acceptability has not been determined. METHODS: Monte Carlo simulations were performed to investigate impact of MSG number on (i) diagnosis based on focus score (FS) ≥1; (ii) reproducibility, defined as the extent to which 2 FS measurements obtained from 2 within-patient biopsies are the same, assuming no systematic differences have occurred in between biopsies; and (iii) smallest sample size required to detect a clinically meaningful difference in FS. Data simulation was repeated for different MSG numbers (range, 2-7). RESULTS: Higher reproducibility was noted for every unit increase in MSG number, with the median absolute difference between 2 within-patient FS measurements decreasing from 1.05 (SD = 0.25) with 2 glands to 0.52 (SD = 0.12) with 7 glands. MSG number influenced the probability of a simulated patient receiving a FS ≥1, increasing from a median of 0.67 with 2 glands to 0.77 with ≥5 glands. MSG number influenced clinical trial sample sizes. For example, 80% statistical power to detect a 40% FS reduction required a sample size per group of 62 with 2 glands and 25 with 7 glands. CONCLUSIONS: For a diagnostic threshold of FS ≥1, a minimum of 5 glands should ideally be targeted. For continuous FS values, a larger number of MSGs (eg, 6) will increase reproducibility further and reduce clinical trial sample size requirements.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Tryposkiadis K, Nayar S, Pucino V, et al. Increasing the number of minor salivary glands from patients with Sjögren's disease improves the diagnostic and measurement precision of the histological focus score. Ann Rheum Dis. 2025. PMID: 39966040. doi:10.1016/j.ard.2025.01.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。